# Hovnanian Enterprises Inc: financial statements, quarterly

HOV · NYSE · CIK 357294 · [Industrials](/sectors/industrials.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/hov.md) · [Financials](/companies/hov/financials.md) · [Filings](/companies/hov/filings.md) · [Insiders](/companies/hov/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hov/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [887 d](/filings/0001753926-25-001938.md) | [594](/filings/0001753926-25-000367.md) | [708](/filings/0001753926-25-000907.md) | [723](/filings/0001753926-25-001413.md) | [980 d](/filings/0001753926-25-001938.md) | [674](/filings/0001753926-26-000412.md) | [686](/filings/0001753926-26-000964.md) | [801](/filings/0001753926-26-001659.md) | [818 d](/filings/0001753926-25-001938.md) | [632](/filings/0001753926-26-000412.md) | [668](/filings/0001753926-26-000964.md) | [706](/filings/0001753926-26-001659.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [24.1 d](/filings/0001753926-25-001938.md) | [8.7](/filings/0001753926-25-000367.md) | [18.6](/filings/0001753926-25-000907.md) | [24.4](/filings/0001753926-25-001413.md) | [23.5 d](/filings/0001753926-25-001938.md) | [11.7](/filings/0001753926-26-000412.md) | [6.8](/filings/0001753926-26-000964.md) | [7.2](/filings/0001753926-26-001659.md) | [(3.4) d](/filings/0001753926-25-001938.md) | [7.8](/filings/0001753926-26-000412.md) | [0.9](/filings/0001753926-26-000964.md) | [(0.6)](/filings/0001753926-26-001659.md) |
| Net income | $m | [97.3 d](/filings/0001753926-25-001938.md) | [23.9](/filings/0001753926-25-001413.md) | [50.8](/filings/0001753926-25-001413.md) | [72.9](/filings/0001753926-25-001413.md) | [94.3 d](/filings/0001753926-25-001938.md) | [28.2](/filings/0001753926-26-001659.md) | [19.7](/filings/0001753926-26-000964.md) | [16.6](/filings/0001753926-26-001659.md) | [(0.7) d](/filings/0001753926-25-001938.md) | [20.9](/filings/0001753926-26-001659.md) | [(0.3)](/filings/0001753926-26-000964.md) | [(1.8)](/filings/0001753926-26-001659.md) |
| Diluted EPS | $ per share | not reported | [2.91](/filings/0001753926-25-000367.md) | [6.66](/filings/0001753926-25-000907.md) | [9.75](/filings/0001753926-25-001413.md) | not reported | [3.58](/filings/0001753926-26-000412.md) | [2.43](/filings/0001753926-26-000964.md) | [1.99](/filings/0001753926-26-001659.md) | not reported | [2.62](/filings/0001753926-26-000412.md) | [(0.46)](/filings/0001753926-26-000964.md) | [(0.70)](/filings/0001753926-26-001659.md) |
| Basic EPS | $ per share | not reported | [3.11](/filings/0001753926-25-000367.md) | [7.12](/filings/0001753926-25-000907.md) | [10.61](/filings/0001753926-25-001413.md) | not reported | [3.88](/filings/0001753926-26-000412.md) | [2.64](/filings/0001753926-26-000964.md) | [2.14](/filings/0001753926-26-001659.md) | not reported | [2.80](/filings/0001753926-26-000412.md) | [(0.46)](/filings/0001753926-26-000964.md) | [(0.70)](/filings/0001753926-26-001659.md) |

- Revenue: us-gaap:Revenues
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,493](/filings/0001753926-24-002117.md) | [2,340](/filings/0001753926-24-000450.md) | [2,318](/filings/0001753926-24-001058.md) | [2,541](/filings/0001753926-24-001518.md) | [2,606](/filings/0001753926-25-001938.md) | [2,533](/filings/0001753926-25-000367.md) | [2,553](/filings/0001753926-25-000907.md) | [2,629](/filings/0001753926-25-001413.md) | [2,634](/filings/0001753926-26-001659.md) | [2,735](/filings/0001753926-26-000412.md) | [2,829](/filings/0001753926-26-000964.md) | [2,861](/filings/0001753926-26-001659.md) |
| Total liabilities | $m | [1,911](/filings/0001753926-24-002117.md) | [1,733](/filings/0001753926-24-000450.md) | [1,671](/filings/0001753926-24-001058.md) | [1,837](/filings/0001753926-24-001518.md) | [1,805](/filings/0001753926-25-001938.md) | [1,722](/filings/0001753926-25-000367.md) | [1,733](/filings/0001753926-25-000907.md) | [1,794](/filings/0001753926-25-001413.md) | [1,803](/filings/0001753926-26-001659.md) | [1,897](/filings/0001753926-26-000412.md) | [2,001](/filings/0001753926-26-000964.md) | [2,040](/filings/0001753926-26-001659.md) |
| Long-term debt | $m | [1,051](/filings/0001753926-24-002117.md) | [935](/filings/0001753926-24-000450.md) | [933](/filings/0001753926-24-001058.md) | [899](/filings/0001753926-24-001518.md) | [896](/filings/0001753926-25-001938.md) | [894](/filings/0001753926-25-000367.md) | [864](/filings/0001753926-25-000907.md) | [862](/filings/0001753926-25-001413.md) | [901](/filings/0001753926-26-001659.md) | [901](/filings/0001753926-26-000412.md) | [902](/filings/0001753926-26-000964.md) | [902](/filings/0001753926-26-001659.md) |
| Shareholders' equity | $m | [582](/filings/0001753926-24-002117.md) | [607](/filings/0001753926-24-000450.md) | [647](/filings/0001753926-24-001058.md) | [703](/filings/0001753926-24-001518.md) | [800](/filings/0001753926-25-001938.md) | [811](/filings/0001753926-26-001659.md) | [820](/filings/0001753926-25-000907.md) | [835](/filings/0001753926-25-001413.md) | [831](/filings/0001753926-26-001659.md) | [836](/filings/0001753926-26-000412.md) | [825](/filings/0001753926-26-000964.md) | [819](/filings/0001753926-26-001659.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [144 d](/filings/0001753926-25-001938.md) | [(89.0)](/filings/0001753926-25-000367.md) | [89.1 d](/filings/0001753926-25-000907.md) | [(92.3) d](/filings/0001753926-25-001413.md) | [116 d](/filings/0001753926-25-001938.md) | [(55.9)](/filings/0001753926-26-000412.md) | [22.3 d](/filings/0001753926-26-000964.md) | [52.8 d](/filings/0001753926-26-001659.md) | [169 d](/filings/0001753926-25-001938.md) | [141](/filings/0001753926-26-000412.md) | [(67.1) d](/filings/0001753926-26-000964.md) | [(24.0) d](/filings/0001753926-26-001659.md) |
| Capital expenditure | $m | [5.6 d](/filings/0001753926-25-001938.md) | [5.4](/filings/0001753926-25-000367.md) | [4.4 d](/filings/0001753926-25-000907.md) | [3.6 d](/filings/0001753926-25-001413.md) | [4.4 d](/filings/0001753926-25-001938.md) | [3.7](/filings/0001753926-26-000412.md) | [6.3 d](/filings/0001753926-26-000964.md) | [7.0 d](/filings/0001753926-26-001659.md) | [5.1 d](/filings/0001753926-25-001938.md) | [8.8](/filings/0001753926-26-000412.md) | [3.4 d](/filings/0001753926-26-000964.md) | [3.8 d](/filings/0001753926-26-001659.md) |
| Dividends paid | $m | [2.7 d](/filings/0001753926-25-001938.md) | not reported | [2.7](/filings/0001753926-25-000907.md) | [2.7](/filings/0001753926-25-001413.md) | [2.7 d](/filings/0001753926-25-001938.md) | not reported | [2.7](/filings/0001753926-25-000907.md) | [2.7](/filings/0001753926-25-001413.md) | [2.7 d](/filings/0001753926-25-001938.md) | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0001753926-25-001938.md) | [0.0](/filings/0001753926-25-000367.md) | [15.1 d](/filings/0001753926-25-000907.md) | [11.4 d](/filings/0001753926-25-001413.md) | [(0.0) d](/filings/0001753926-25-001938.md) | [18.1](/filings/0001753926-26-000412.md) | [12.3 d](/filings/0001753926-26-000964.md) | [(0.1) d](/filings/0001753926-26-001659.md) | [(0.1) d](/filings/0001753926-25-001938.md) | [9.0](/filings/0001753926-26-000412.md) | [9.5 d](/filings/0001753926-26-000964.md) | [(0.1) d](/filings/0001753926-26-001659.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-31) | Q2 FY2023 (2023-04-30) | Q3 FY2023 (2023-07-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,468](/filings/0001753926-24-000450.md) | [6,462](/filings/0001753926-24-001058.md) | [6,705](/filings/0001753926-24-001518.md) | [6,937](/filings/0001753926-25-000367.md) | [6,902](/filings/0001753926-25-000907.md) | [7,048](/filings/0001753926-25-001413.md) | [7,071](/filings/0001753926-26-000412.md) | [6,951](/filings/0001753926-26-000964.md) | [6,887](/filings/0001753926-26-001659.md) | [6,950](/filings/0001753926-26-000412.md) | [6,416](/filings/0001753926-26-000964.md) | [6,412](/filings/0001753926-26-001659.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 720,307 at 2023-03-01, from the cover of the [10-Q filed 2023-03-06](/filings/0001437749-23-005546.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.